Sanofi to acquire Kadmon for $1.9 billion
MLex Summary: Sanofi has agreed to purchase Kadmon, "a biopharmaceutical company that discovers, develops and markets transformative therapies for unmet medical needs," for $1.9 billion. Both companies are traded on the...To view the full article, register now.
Already a subscriber? Click here to view full article